ChestPal®

ChestPal® is dedicated to transforming respiratory health through innovative technology and a commitment to accessibility. Focused on early detection and timely intervention for life-threatening respiratory conditions, ChestPal® provides solutions for frontline healthcare providers, enhancing their ability to reliably detect crackles and wheezes, ultimately aiding in diagnosis and patient management.

With a strong emphasis on quality and compliance, ChestPal® adheres to internationally recognized standards and rigorous testing practices. The company’s commitment to safety and efficacy is evident in its ISO 13485 certification and compliance with all applicable FDA requirements. ChestPal® is also dedicated to protecting sensitive information, with designated HIPAA privacy and security compliance officers, policies, procedures, and technical measures in place.

ChestPal® operates from multiple locations, including its primary address in England, GB, as well as 1175 Peachtree St NE, Suite 1000, Atlanta, Georgia 30361, US, and 63 Ship Street, Brighton and Hove, England BN1 1AE, GB. We invite the management team at ChestPal® to create a customized and exclusive company showcase and product listing on our platform to further amplify their reach and impact.